cisatracurium besylate

Generic: cisatracurium besylate

Labeler: somerset therapeutics, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cisatracurium besylate
Generic Name cisatracurium besylate
Labeler somerset therapeutics, llc
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

cisatracurium besylate 2 mg/mL

Manufacturer
Somerset Therapeutics, LLC

Identifiers & Regulatory

Product NDC 70069-141
Product ID 70069-141_757aedc0-ad65-446a-81ed-09afbe8cc595
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206791
Listing Expiration 2026-12-31
Marketing Start 2019-02-04

Pharmacologic Class

Classes
neuromuscular nondepolarizing blockade [pe] nondepolarizing neuromuscular blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70069141
Hyphenated Format 70069-141

Supplemental Identifiers

RxCUI
199212 1730194
UPC
0370069141014 0370069151013
UNII
80YS8O1MBS

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cisatracurium besylate (source: ndc)
Generic Name cisatracurium besylate (source: ndc)
Application Number ANDA206791 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (70069-141-01) / 5 mL in 1 VIAL
  • 10 VIAL in 1 CARTON (70069-141-10) / 5 mL in 1 VIAL
source: ndc

Packages (2)

70069-141-01 1 VIAL in 1 CARTON (70069-141-01) / 5 mL in 1 VIAL 70069-141-10 10 VIAL in 1 CARTON (70069-141-10) / 5 mL in 1 VIAL

Ingredients (1)

cisatracurium besylate (2 mg/mL)

Linked Drug Pages (1)

Cisatracurium Besylate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "757aedc0-ad65-446a-81ed-09afbe8cc595", "openfda": {"upc": ["0370069141014", "0370069151013"], "unii": ["80YS8O1MBS"], "rxcui": ["199212", "1730194"], "spl_set_id": ["ed91f65b-e002-43bd-bfa0-5ce8b89119e6"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (70069-141-01)  / 5 mL in 1 VIAL", "package_ndc": "70069-141-01", "marketing_start_date": "20190204"}, {"sample": false, "description": "10 VIAL in 1 CARTON (70069-141-10)  / 5 mL in 1 VIAL", "package_ndc": "70069-141-10", "marketing_start_date": "20190204"}], "brand_name": "Cisatracurium Besylate", "product_id": "70069-141_757aedc0-ad65-446a-81ed-09afbe8cc595", "dosage_form": "INJECTION", "pharm_class": ["Neuromuscular Nondepolarizing Blockade [PE]", "Nondepolarizing Neuromuscular Blocker [EPC]"], "product_ndc": "70069-141", "generic_name": "Cisatracurium Besylate", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cisatracurium Besylate", "active_ingredients": [{"name": "CISATRACURIUM BESYLATE", "strength": "2 mg/mL"}], "application_number": "ANDA206791", "marketing_category": "ANDA", "marketing_start_date": "20190204", "listing_expiration_date": "20261231"}